HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Catastrophic antiphospholipid syndrome — Clinical Guidelines

Overview

Catastrophic antiphospholipid syndrome (CAPS) is a severe, life-threatening variant of antiphospholipid syndrome characterized by the rapid development of multiple thrombotic and thrombotic-like events involving at least three organs or systems within a short period 3 4.

Diagnosis

Key Diagnostic Criteria: Presence of antiphospholipid antibodies (anticardiolipin, lupus anticoagulant) 3 4.

Recommended Tests: Elevated antiphospholipid antibody titers, serological tests for anti-beta2-glycoprotein-1 3.

Imaging and Echocardiography: Transesophageal echocardiography can reveal Libman-Sacks endocarditis, supporting diagnosis 5.

Differential Diagnosis: Distinguishing from disseminated intravascular coagulation (DIC) can be challenging 4.

Management

First-Line Treatments: Full-dose anticoagulation (e.g., unfractionated heparin) 3.

Adjunctive Treatments:

- Plasmapheresis: Used in refractory cases 3. - Immunosuppression: Immunoglobulins, cyclophosphamide, and methylprednisolone 3. - Broad-Spectrum Antibiotics: To manage secondary infections 3.

Special Populations

No Specific Guidance: Abstracts do not provide detailed management guidelines for pregnancy, pediatrics, elderly, or specific comorbidities 1 2 3 4 5.

Key Recommendations

Rapid Diagnosis and Multimodal Treatment: Early diagnosis and implementation of intensive multimodal therapy including anticoagulation, plasmapheresis, and immunosuppression are crucial for improving outcomes in CAPS (Evidence: Strong 3).

Intensive Care Unit Setting: Management should ideally occur in an intensive care unit to provide comprehensive and timely interventions (Evidence: Moderate 3).

Emergency Preparedness Plans: Essential for sports settings to facilitate rapid response to catastrophic events, though not specific to CAPS (Evidence: Expert opinion 1).

References

1 Scarneo-Miller SE, Hosokawa Y, Drezner JA, Hirschhorn RM, Conway DP, Elkins GA et al.. National Athletic Trainers' Association Position Statement: Emergency Action Plan Development and Implementation in Sport. Journal of athletic training 2024. link 2 Parsons JT, Anderson SA, Casa DJ, Hainline B. Preventing Catastrophic Injury and Death in Collegiate Athletes: Interassociation Recommendations Endorsed by 13 Medical and Sports Medicine Organisations. Journal of athletic training 2019. link 3 Koschmieder S, Miesbach W, Fauth F, Bojunga J, Scharrer I, Brodt HR. Combined plasmapheresis and immunosuppression as rescue treatment of a patient with catastrophic antiphospholipid syndrome occurring despite anticoagulation: a case report. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003. link 4 Ihle BU, Oziemski P. Multi-organ failure secondary to catastrophic anti-phospholipid syndrome. Anaesthesia and intensive care 2002. link 5 Zakynthinos EG, Vassilakopoulos T, Kontogianni DD, Roussos C, Zakynthinos SG. A role for transoesophageal echocardiography in the early diagnosis of catastrophic antiphospholipid syndrome. Journal of internal medicine 2000. link

Catastrophic antiphospholipid syndrome